Wensi Liu
Overview
Explore the profile of Wensi Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai H, Liu W, Zhou K, Wang X, Lin K, Tang X
Sensors (Basel)
. 2024 Jul;
24(14).
PMID: 39065918
Ultrasonic flow meters are crucial measuring instruments in natural gas transportation pipeline scenarios. The collected flow velocity data, along with the operational conditions data, are vital for the analysis of...
2.
Liu W, Li Z, Xie Y, He A, Hao D, Dong A
Am J Phys Med Rehabil
. 2022 Mar;
101(4):358-366.
PMID: 35302529
Objective: The aim of the study was to identify the effects of combined motor imagery and action observation therapy on vascular cognitive impairment. Design: Thirty vascular cognitive impairment patients were...
3.
Liu W, Yu Z, Tang H, Wang X, Zhang B, Zhao J, et al.
EBioMedicine
. 2021 Nov;
74:103710.
PMID: 34823109
No abstract available.
4.
Li L, Liu W, Tang H, Wang X, Liu X, Yu Z, et al.
Am J Cancer Res
. 2021 Nov;
11(10):5076-5093.
PMID: 34765313
Hypoxia is a common feature of tumor microenvironment (TME). This study aims to establish the genetic features related to hypoxia in Bladder urothelial carcinoma (BLCA) and investigate the potential correlation...
5.
Yu J, Wang S, Qi J, Yu Z, Xian Y, Liu W, et al.
Int Immunopharmacol
. 2021 Oct;
101(Pt A):108148.
PMID: 34653955
Background: Based on the interaction between cytotoxic T lymphocyte (CTL) dominant epitopes and dendritic cells (DCs), CD8T cells are specifically activated into CTL cells. Targeted killing is a type of...
6.
Yu Z, Liu W, He Y, Sun M, Yu J, Jiao X, et al.
J Hematol Oncol
. 2021 Sep;
14(1):158.
PMID: 34587994
No abstract available.
7.
Wang X, Yu Z, Liu W, Tang H, Yi D, Wei M
Am J Cancer Res
. 2021 Jul;
11(6):2401-2416.
PMID: 34249407
Tumor immunotherapy has now become one of the most potential therapy for those intractable cancer diseases. The antigens on the cancer cell surfaces are the keys for the immune system...
8.
Tang H, Liu W, Xu Z, Zhao J, Wang W, Yu Z, et al.
J Cell Mol Med
. 2021 May;
25(12):5534-5546.
PMID: 33960636
Glioblastoma (GBM) is the most common malignant intracranial tumour with intrinsic infiltrative characteristics, which could lead to most patients eventually relapse. The prognosis of recurrent GBM patients remains unsatisfactory. Cancer...
9.
Yu Z, Liu W, He Y, Sun M, Yu J, Jiao X, et al.
J Hematol Oncol
. 2021 Apr;
14(1):71.
PMID: 33910591
Background: CD8 T cell-mediated adaptive cellular immunity and natural killer (NK) cell-mediated innate immunity both play important roles in tumour immunity. This study aimed to develop therapeutic tumour vaccines based...
10.
Liu W, Tang H, Li L, Wang X, Yu Z, Li J
Cell Prolif
. 2021 Mar;
54(5):e13025.
PMID: 33754407
The peptide-based therapeutic cancer vaccines have attracted enormous attention in recent years as one of the effective treatments of tumour immunotherapy. Most of peptide-based vaccines are based on epitope peptides...